Incidence of Cardiovascular Complications and Nephropathy in Patients with Type 2 Diabetes in a Primary Care Setting in Riyadh, Saudi Arabia

Figures & data

Table 1 General Characteristics (Original)

Age at time of diagnosis (years)	50.07 (11.354)
Duration of follow-up (years)	7.14 (3.903)
Male gender	47.1%
Female gender	52.9%
Last visit–body mass index	30.86 (5.849)
First visit–body mass index	30.88 (6.055)
Last visit–systolic blood pressure	129.79 (15.859)
Last visit–diastolic blood pressure	77.15 (9.547)
First visit–systolic blood pressure	127.25 (17.997)
First visit–diastolic blood pressure	79.02 (48.633)
Last visit–creatinine	71.62 (20.510)
First visit–creatinine	78.26 (19.010)
Last visit–fasting blood glucose	7.72 (2.526)
First visit–fasting blood glucose	5.82 (0.776)
Last visit–hemoglobin A1C	0.071 (014)
Middle visit–hemoglobin A1C	0.084 (0.128)
First visit–hemoglobin A1C	0.070 (0.042)
Last visit–low-density lipoprotein	2.70 (0.889)
First visit–low-density lipoprotein	3.17 (0.926)

Note: The data are the numbers and percentages of patients, the mean, and the standard deviation.

Table 2 Frequency of Complications and Comorbidities Among Patients with Type 2 Diabetes Mellitus (n=365) (Original)

	N	Age at Onset of the Complication	Duration of the Development of the Complication
Dyslipidemia	68	52.65 (12.619)	3.76 (3.33)
Hypertension	67	51.34 (10.928)	3.73 (3.255)
Hypothyroidism	22	52.95 (10.684)	2.36 (3.274)
Cardiovascular	41	58.22 (12.2)	6.02 (3.984)
Diabetic nephropathy	38	57.3 (10.2)	5.24 (3.2)

Note: The data are the mean ± (standard deviation) and range in years.

Figure 1 Rate of developing cardiovascular and diabetic nephropathy among patients with type 2 diabetes mellitus.